Author et al | Animal type | Model | Intervention used to target Nrf2 signaling pathway | Outcomes |
---|---|---|---|---|
Kyei et al. [58] | Mice | In vitro | Vitamin D3 + MitoQ10 | • Decrease serum MDA, SOD, and hormone levels* • Reduction in steroidogenesis-related enzymes and OS-associated mRNA Nrf2 pathway |
Kabel et al. [59] | Rat | In vivo | linagliptin and I3C | • Reduced levels of markers like TGF-β1, TNF-α, and IL-10, as well as hormone levels • Antioxidant enzyme activity (Nrf2/HO-1) increased • Reduced body weight, fasting blood glucose, insulin levels and improved ovarian morphology |
Ibrahim et al. [61] | Rat | In vivo | Diacerein 50&25 mg/kg | • Reducing elevated levels of MDA and total nitrite • Enhance the protective proteins Keap-1, Nrf2, and OH-1 level • Inhibit the elevated mRNA levels inflammatory cytokines • Decrease body and ovarian weight, cyst formation, insulin, glucose, hormone levels |
Akin et al. [60] | Human | In vitro | amphiregulin | • Promoted the maturation rate of oocytes • The expression Change of genes involved in steroidogenesis, ovulation, and metabolism |
Huang et al. [62] | Rat | In vivo | Luteolin | • Reduces insulin resistance by activating the PI3K/AKT signaling pathway • Preserving oocytes and corpus luteum • Normalized the hormone imbalances |
Gharaei et al. [63] | Human | In vivo | Astaxanthin | • Increase expression of Nrf2, HO-1, and NQ-1 in GCs • Raises of serum level CAT and TAC |
Taheri et al. [64] | Human | In vivo | Sulforaphane | • Reduced intracellular ROS and apoptosis in GC • Activation of the AMPK/AKT/NRF2 signaling pathway |
Zheng et al. [65] | Mic | In vivo | Qi Gong Wan (QGW) | • Improve cystic follicles, fasting insulin, and HOMA-IR index • By activating the Nrf2/HO1/Cyp1b1 pathway to improve adipocyte hypertrophy and inflammation |
Wang et al. [66] | Rat, COV434 cell lines | in vivo and in vitro | Humanin | • Humanin Supplementation reduced body weight gain, Improved ovarian morphology and endocrinological disorders • Modulation of Nrf2/HO1/Cyp1b1 pathway |
Zhang et al. [76] | KGN cells | in vitro | miR-873-5p inhibitor | • suppressed cell apoptosis, decrease in OS, and reduced production of ROS and MDA • activated the p38/Nrf2/HO-1 signaling pathway |
Tan et al. [68] | KGN cells | In vitro | miR-93-5p | • miR-93-5p upregulated in the GCs • Overexpression of miR-93- promoted apoptosis and ferroptosis GCs • Silencing of miR-93-5p protects against GC dysfunction |
Olaniyi et al. [69] | Rat | In vivo | Sodium acetate (200 mg/kg), oral | • Normal follicular development and improved circulating 17-β estradiol levels • Increasing ovarian levels of glutathione peroxidase, and Nrf2 • Reductions in body and ovarian weigh |